Product
PMT
1 clinical trial
5 indications
Indication
Multidrug-resistant Bacterial InfectionIndication
Enterobacteriaceae InfectionsIndication
Pseudomonas aeruginosaIndication
MRSAClinical trial
A Phase II Randomized Trial to Evaluate the Impact of Fecal Microbiota Transplantation Using the Penn Microbiome Therapy Products on Recipient and Environmental Colonization With Multidrug-Resistant OrganismsStatus: Not yet recruiting, Estimated PCD: 2026-01-01